- Home
- LEGN vs AXS Comparison
LEGN vs AXS Comparison
Compare LEGN & AXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- AXS
- Stock Information
- Founded
- LEGN 2014
- AXS 2001
- Country
- LEGN United States
- AXS Bermuda
- Employees
- LEGN N/A
- AXS N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- AXS Property-Casualty Insurers
- Sector
- LEGN Health Care
- AXS Finance
- Exchange
- LEGN Nasdaq
- AXS Nasdaq
- Market Cap
- LEGN 7.0B
- AXS 8.1B
- IPO Year
- LEGN 2020
- AXS N/A
- Fundamental
- Price
- LEGN $27.78
- AXS $102.54
- Analyst Decision
- LEGN Strong Buy
- AXS Strong Buy
- Analyst Count
- LEGN 13
- AXS 9
- Target Price
- LEGN $75.67
- AXS $107.75
- AVG Volume (30 Days)
- LEGN 1.5M
- AXS 565.6K
- Earning Date
- LEGN 05-13-2025
- AXS 04-30-2025
- Dividend Yield
- LEGN N/A
- AXS 1.72%
- EPS Growth
- LEGN N/A
- AXS 54.31
- EPS
- LEGN N/A
- AXS 10.08
- Revenue
- LEGN $728,303,000.00
- AXS $6,055,200,000.00
- Revenue This Year
- LEGN $65.96
- AXS $4.15
- Revenue Next Year
- LEGN $52.55
- AXS $5.74
- P/E Ratio
- LEGN N/A
- AXS $10.14
- Revenue Growth
- LEGN 112.46
- AXS 5.79
- 52 Week Low
- LEGN $29.27
- AXS $68.02
- 52 Week High
- LEGN $60.87
- AXS $101.42
- Technical
- Relative Strength Index (RSI)
- LEGN 29.61
- AXS 64.39
- Support Level
- LEGN $30.25
- AXS $98.40
- Resistance Level
- LEGN $33.30
- AXS $102.36
- Average True Range (ATR)
- LEGN 1.78
- AXS 2.23
- MACD
- LEGN -0.57
- AXS 0.26
- Stochastic Oscillator
- LEGN 5.19
- AXS 99.79
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About AXS Axis Capital Holdings Limited
Axis Capital Holdings Ltd is a specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States ("U.S."), Europe, Singapore, and Canada. The company manages its portfolio holistically, aiming to construct an optimum consolidated portfolio of funded and unfunded risks. The company's segment consists of AXIS Insurance and AXIS Reinsurance. The company generates the majority of its revenue from the Insurance segment. Geographically, the company generates the majority of its revenue from the United States.